Straumann Group, headquartered in Basel, Switzerland, is a global leader in implant, restorative, and regenerative dentistry. Since its founding in 1954, the company has been at the forefront of dental innovation, pioneering implant surface technologies and advancing digital workflow solutions. Straumann’s core business encompasses the design, development and distribution of dental implants, prosthetic components, and biomaterials that support tissue regeneration and long-term oral health.
The company offers a comprehensive portfolio of products and services that span the entire patient journey—from initial diagnosis and treatment planning to final restoration and aftercare. Straumann’s flagship implant systems include titanium and ceramic implants designed for predictable integration. Its biomaterials division provides bone grafts, membranes and tissue regeneration products under brands such as Geistlich, while its digital dentistry arm delivers intraoral scanners, CAD/CAM solutions and software platforms that enable clinicians to streamline treatment protocols and enhance patient outcomes. Straumann has also expanded into orthodontics with clear aligner therapy and practice management tools to support dental professionals in optimizing efficiency and patient satisfaction.
Straumann operates in more than 100 countries through a network of regional subsidiaries and distribution partners. Key markets include Europe, North America, Asia Pacific and Latin America, where the company serves a diverse customer base of dental specialists, general practitioners and dental laboratories. Straumann invests significantly in research and development, collaborating with academic institutions and clinical partners to validate new technologies and refine treatment methodologies. Its commitment to education is reflected in sponsored courses, training programs and digital learning platforms that support the ongoing professional growth of dental clinicians worldwide.
Under the leadership of Chief Executive Officer Guillaume Daniellot and a senior management team with deep experience in medical devices and healthcare services, Straumann continues to pursue its strategy of sustainable growth and innovation. The company’s governance framework, led by an independent board of directors, emphasizes ethical conduct, regulatory compliance and responsible business practices. By combining its heritage in implant dentistry with a forward-looking approach to digitalization and regenerative science, Straumann aims to set new standards in patient care and to strengthen its position in the evolving global dental market.
AI Generated. May Contain Errors.
Free SAUHF Stock Alerts